Ausgabe 2/2017
Inhalt (6 Artikel)
A comprehensive review of paediatric low-grade diffuse glioma: pathology, molecular genetics and treatment
Scott Ryall, Uri Tabori, Cynthia Hawkins
Bevacizumab for malignant gliomas: current indications, mechanisms of action and resistance, and markers of response
Ryota Tamura, Toshihide Tanaka, Keisuke Miyake, Kazunari Yoshida, Hikaru Sasaki
Genetic aberrations and molecular biology of skull base chordoma and chondrosarcoma
Yohei Kitamura, Hikaru Sasaki, Kazunari Yoshida
A novel all-in-one intraoperative genotyping system for IDH1-mutant glioma
Fumiharu Ohka, Akane Yamamichi, Michihiro Kurimoto, Kazuya Motomura, Kuniaki Tanahashi, Hiromichi Suzuki, Kosuke Aoki, Shoichi Deguchi, Lushun Chalise, Masaki Hirano, Akira Kato, Yusuke Nishimura, Masahito Hara, Yukinari Kato, Toshihiko Wakabayashi, Atsushi Natsume
A case of glioblastoma resected immediately after administering bevacizumab: consideration on histopathological findings and safety of surgery
Yukina Tokuda, Ryota Tamura, Kentaro Ohara, Kazunari Yoshida, Hikaru Sasaki